Why the study?
Does chronic treatment with dimethylthiourea prevent endothelial dysfunction in streptozotocin-induced diabetic rats?
Population
Lewis strain rats made diabetic by intravenous injection of streptozotocin
Comparison
Dimethylthiourea 50 mg/kg daily intraperitoneal… vs Diabetic rats not receiving DMTU
Design
Preclinical
Follow-up
8 weeks
Authors
Loading...
Supports hydroxyl radical scavenging to preserve endothelial function in diabetic rats; leaves open clinical translation of antioxidant strategies.
Does chronic treatment with dimethylthiourea prevent endothelial dysfunction in streptozotocin-induced diabetic rats?
Chronic in vivo treatment with the hydroxyl radical scavenger dimethylthiourea prevents diabetes-induced endothelial dysfunction in rats without altering glycemic control, highlighting the role of oxidative stress in vascular complications.
Pieper et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: